1
|
Rimbert A, Yeung MW, Dalila N, Thio CHL, Yu H, Loaiza N, Oldoni F, van der Graaf A, Wang S, Said MA, Blauw LL, Girardeau A, Bray L, Caillaud A, Bloks VW, Marrec M, Moulin P, Rensen PCN, van de Sluis B, Snieder H, Di Filippo M, van der Harst P, Tybjaerg-Hansen A, Zimmerman P, Cariou B, Kuivenhoven JA. Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile. Arterioscler Thromb Vasc Biol 2022; 42:1262-1271. [PMID: 36047410 DOI: 10.1161/atvbaha.122.317514] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND In mice, GPR146 (G-protein-coupled receptor 146) deficiency reduces plasma lipids and protects against atherosclerosis. Whether these findings translate to humans is unknown. METHODS Common and rare genetic variants in the GPR146 gene locus were used as research instruments in the UK Biobank. The Lifelines, The Copenhagen-City Heart Study, and a cohort of individuals with familial hypobetalipoproteinemia were used to find and study rare GPR146 variants. RESULTS In the UK Biobank, carriers of the common rs2362529-C allele present with lower low-density lipoprotein cholesterol, apo (apolipoprotein) B, high-density lipoprotein cholesterol, apoAI, CRP (C-reactive protein), and plasma liver enzymes compared with noncarriers. Carriers of the common rs1997243-G allele, associated with higher GPR146 expression, present with the exact opposite phenotype. The associations with plasma lipids of the above alleles are allele dose-dependent. Heterozygote carriers of a rare coding variant (p.Pro62Leu; n=2615), predicted to be damaging, show a stronger reductions in the above parameters compared with carriers of the common rs2362529-C allele. The p.Pro62Leu variant is furthermore shown to segregate with low low-density lipoprotein cholesterol in a family with familial hypobetalipoproteinemia. Compared with controls, carriers of the common rs2362529-C allele show a marginally reduced risk of coronary artery disease (P=0.03) concomitant with a small effect size on low-density lipoprotein cholesterol (average decrease of 2.24 mg/dL in homozygotes) of this variant. Finally, mendelian randomization analyses suggest a causal relationship between GPR146 gene expression and plasma lipid and liver enzyme levels. CONCLUSIONS This study shows that carriers of new genetic GPR146 variants have a beneficial cardiometabolic risk profile, but it remains to be shown whether genetic or pharmaceutical inhibition of GPR146 protects against atherosclerosis in humans.
Collapse
Affiliation(s)
- Antoine Rimbert
- Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (A.R., A.G., L.B., A.C., M.M., B.C.)
| | - Ming W Yeung
- Department of Cardiology (M.W.Y., S.W., M.S., P.v.d.H.), University Medical Center Groningen, University of Groningen, the Netherlands.,Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, the Netherlands (M.W.Y., P.v.d.H.)
| | - Nawar Dalila
- Section for Molecular Genetics, Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (N.D., A.T.-H.)
| | - Chris H L Thio
- Department of Epidemiology (C.H.L.T., S.W., H.S.), University Medical Center Groningen, University of Groningen, the Netherlands
| | - Haojie Yu
- Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (H.Y.).,Precision Medicine Research Programme, Yong Loo Lin School of Medicine, National University of Singapore (H.Y.)
| | - Natalia Loaiza
- Department of Pediatrics, Section Molecular Genetics (N.L., B.v.d.S., J.A.K.), University Medical Center Groningen, University of Groningen, the Netherlands
| | - Federico Oldoni
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas (F.O.)
| | - Adriaan van der Graaf
- Department of Genetics (A.v.d.G.), University Medical Center Groningen, University of Groningen, the Netherlands
| | - Siqi Wang
- Department of Cardiology (M.W.Y., S.W., M.S., P.v.d.H.), University Medical Center Groningen, University of Groningen, the Netherlands.,Department of Epidemiology (C.H.L.T., S.W., H.S.), University Medical Center Groningen, University of Groningen, the Netherlands
| | - M Abdullah Said
- Department of Cardiology (M.W.Y., S.W., M.S., P.v.d.H.), University Medical Center Groningen, University of Groningen, the Netherlands
| | - Lisanne L Blauw
- Department of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, the Netherlands (L.L.B., P.C.N.R.)
| | - Aurore Girardeau
- Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (A.R., A.G., L.B., A.C., M.M., B.C.)
| | - Lise Bray
- Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (A.R., A.G., L.B., A.C., M.M., B.C.)
| | - Amandine Caillaud
- Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (A.R., A.G., L.B., A.C., M.M., B.C.)
| | - Vincent W Bloks
- Sections of Molecular Metabolism and Nutrition, Department of Pediatrics (V.W.B.), University Medical Center Groningen, University of Groningen, the Netherlands
| | - Marie Marrec
- Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (A.R., A.G., L.B., A.C., M.M., B.C.)
| | - Philippe Moulin
- CarMen Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France (P.M., M.D.F.).,Hospices Civils de Lyon, Fédération d'endocrinologie, maladies métaboliques, diabète et nutrition, Hôpital Louis Pradel, Bron, France (P.M.)
| | - Patrick C N Rensen
- Department of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, the Netherlands (L.L.B., P.C.N.R.)
| | - Bart van de Sluis
- Department of Pediatrics, Section Molecular Genetics (N.L., B.v.d.S., J.A.K.), University Medical Center Groningen, University of Groningen, the Netherlands
| | - Harold Snieder
- Department of Epidemiology (C.H.L.T., S.W., H.S.), University Medical Center Groningen, University of Groningen, the Netherlands
| | - Mathilde Di Filippo
- CarMen Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France (P.M., M.D.F.).,Hospices Civils de Lyon, UF Dyslipidémies Service de Biochimie et de Biologie Moléculaire Grand Est, Bron, France (M.D.F.)
| | - Pim van der Harst
- Department of Cardiology (M.W.Y., S.W., M.S., P.v.d.H.), University Medical Center Groningen, University of Groningen, the Netherlands.,Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, University of Utrecht, the Netherlands (M.W.Y., P.v.d.H.)
| | - Anne Tybjaerg-Hansen
- Section for Molecular Genetics, Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (N.D., A.T.-H.).,Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark (A.T.-H.).,The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Denmark (A.T.-H.)
| | | | - Bertrand Cariou
- Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (A.R., A.G., L.B., A.C., M.M., B.C.)
| | - Jan Albert Kuivenhoven
- Department of Pediatrics, Section Molecular Genetics (N.L., B.v.d.S., J.A.K.), University Medical Center Groningen, University of Groningen, the Netherlands
| |
Collapse
|
5
|
Yau TK, Lau Y, Kong J, Yeung MW, Chan M, Sze WM, Cheung P, Lim BH, Lee A. Breast conservation treatment in Hong Kong-early results of 203 patients: retrospective study. Hong Kong Med J 2002; 8:322-8. [PMID: 12376708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/26/2023] Open
Abstract
OBJECTIVE To study the clinical outcomes of patients with invasive or non-invasive breast cancer after breast conservation treatment. DESIGN Retrospective study. SETTING Clinical oncology department of a public hospital, Hong Kong. PATIENTS Two hundred and three patients who received postlumpectomy radiotherapy at the Pamela Youde Nethersole Eastern Hospital between January 1994 and June 1999. INTERVENTIONS Adjuvant radiotherapy with or without systemic adjuvant treatment. MAIN OUTCOME MEASURES Actuarial local control rate, progression-free survival rate, disease-specific survival rate, and cosmetic score. RESULTS The median follow-up was 3.5 years. Two of the 25 patients with carcinoma in situ only developed local recurrence; the 5-year actuarial local control rate was 91.3%. Among the 178 patients with invasive cancer, seven had a local recurrence and 12 developed distant metastases without local failure. The 5-year actuarial local control, progression-free survival, and disease-specific survival rates for patients with invasive cancer were 95.5%, 85.8%, and 95.2%, respectively. The risk of local recurrence was significantly increased for younger patients (age <40 years) and those with positive final margins. Cosmetic scores were rated good to excellent by 95.6% of patients. CONCLUSIONS The early clinical outcomes of these patients are comparable to those in large overseas trials, which have demonstrated the equivalence of mastectomy and breast conservation treatment in terms of survival. In addition to mastectomy, with or without breast reconstruction, breast conservation treatment should be offered as an alternative to suitable Chinese women. To maximise local control, further excision or mastectomy is recommended for patients with positive final margins.
Collapse
Affiliation(s)
- T K Yau
- Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong
| | | | | | | | | | | | | | | | | |
Collapse
|